Pharmaceutical supplier STADA Philippines, an affiliate of German-based STADA Arzneimittel AG, has chosen global healthcare solutions company Zuellig Pharma as its exclusive distribution partner starting Jan. 1, 2024.
As the sole distribution partner of STADA in the Philippines, Zuellig will be able to expand STADA's over-the-counter, consumer brands, and prescription medicine products to more than 6,000 pharmacies, supermarkets, hospitals, and clinics nationwide.
It will promote products under brands such as FERN-C vitamin C, the Oilatum skincare line and Hyabak eye drops, along with essential generic medicines like antibiotics and cardiovascular therapies.
As a start, Zuellig has distributed around 70 stock-keeping units for STADA.
Zuellig Pharma's Managing Director for the Philippines Jannette A. Jakosalem said that the fim is “confident that our longstanding presence in the Philippines and our strong in-market capabilities will enable us to continue to meet the needs of the population.”
“The Philippines is a key strategic market within STADA’s ambitious growth plans in South-East Asia. This partnership with Zuellig Pharma will substantially drive the growth of our portfolio in the Philippines and will enable greater access for our products in the market,” remarked STADA’s Head of Emerging Markets Stéphane Jacqmin.
STADA Philippines General Manager Paolo Valenzuela noted that their alliance with Zuellig will elevate their business and deliver positive outcomes for the company.
“We are confident that Zuellig Pharma’s extensive network and its proven track record in pharmaceutical distribution and healthcare services will be pivotal in helping us enhance our reach and capabilities within the Philippines. This alliance will elevate our business to the next level and enable us to deliver on our growth ambition as a key player in the market,” said Valenzuela.